Patents/Assignees

Janssen Pharmaceutica NV

136 patents in portfolio

US12617796utility2026
Antagonists of the Adenosine A2a Receptor
0 cites
US12577243utility2026
Monoacylglycerol Lipase Modulators
0 cites
US12570658utility2026
Synthetic Methods of Making (2H-1, 2, 3-triazol-2-yl) Phenyl Compounds as Orexin Receptor Modulators
0 cites
US12559496utility2026
Imidazopyrimidines as Modulators of IL-17
0 cites
US12545677utility2026
Compounds Useful as Factor Xia Inhibitors
0 cites
US12502378utility2025
Monoacylglycerol Lipase Modulators for Use in Autism Spectrum Disorders
0 cites
US12492194utility2025
HPK1 Inhibitors
0 cites
US12486264utility2025
Bicyclic HPK1 Inhibitors
0 cites
US12473295utility2025
Substituted Straight Chain Spiro Derivatives
0 cites
US12472184utility2025
Dosing Regimens Associated with Extended Release Paliperidone Injectable Formulations
0 cites
US12459948utility2025
Processes and Intermediates for Preparing a Btk Inhibitor
0 cites
US12441801utility2025
Anti-vista Antibodies and Fragments, Uses Thereof, and Methods of Identifying Same
0 cites
US12433880utility2025
Methods for the Treatment of Neurological Disorders
0 cites
US12404260utility2025
Pyridine Rings Containing Derivatives as MALT1 Inhibitors
0 cites
US12398155utility2025
Thienopyridinone Compounds
0 cites
US12390451utility2025
Small Molecule Inhibitor of the JAK Family of Kinases
0 cites
US12383543utility2025
Methods of Treating Prostate Cancer
0 cites
US12383635utility2025
Radiolabelled MGL PET Ligands
0 cites
US12378246utility2025
Synthetic Options Towards the Manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-one
0 cites
US12378254utility2025
Disubstituted Octahydropyrrolo[3,4-c]pyrroles as Orexin Receptor Modulators
0 cites

Page 1 of 7Next →